SPEAKER BIOGRAPHICAL INFORMATION

SPEAKER BIOGRAPHICAL INFORMATION

Madeleine R. Valera MD, MScIH (Heidelberg) Dr. Valera is a senior health care service professional with over 20 years of professional expertise in Health Financing and Pharmaco-Economics, Quality Assurance, Health Techonology Assessment, Primary Health Care Service Delivery, Policy Development, and Financing Management in the Public and Private Sectors. She is currently the Senior Vice President with a national social health insurance organization, the Philippine Health Insurance Corporation (PHIC), overseeing the following: Quality Assurance, Benefit Development, Policy Development, and Developing Standards of Accreditation. She has vast experience in developing PHIC benefits and in drug and health care financing. Dr. Valera has significant experience in policy development, having assisted in the formulation of the National Policy Agenda for such health and development issues as Minimum Basic Needs, Devolution, Poverty Alleviation, and Social Reform, Population Policy, NGO-GO Collaboration and Partnership in Health and Alternative Medicine, many of which were later translated into Philippine Law. Dr. Valera has been acting as field tutor/mentor of the interns from Heidelberg University in Germany and the Youth Internship Program (YIP) of the Canadian International Development Authority (CIDA) since 2000. Likewise, she is involved in the development of course modules for Health Care Governance, Medical Records Management and Health Information Management. Dr. Valera was a research fellow under the Pyle Fellowship and Pharmaceutical Policy Fellowship of DACP Harvard Medical School. Her researches covered performance monitoring of health insurance benefits focused on quality, equity, access, efficiency/effectiveness, development of outpatient drug benefits for vaccination and chronic illness, as well as development of medicare policy.

Jie Chen PhD Professor of Department of Hospital Management, School of Public Health, Fudan University; Director of National Key Lab of Health Technology Assessment, Ministry of Health (MOH) (Fudan University); Head of the WHO Collaborating Centre for Health Technology Assessment and Management; Consultant of National Institute of Hospital Management, MOH, China; Foundation Council member and STRATEC member of Global Forum for Health Research; Editor Committee member of International Health Technology Assessment Magazine; Board member of Global Alliance against Chronic Respiratory Disease (GARD); Member and the Chairman elect of Medical Device and Diagnosis Committee in Asia Pacific region, International Society for Pharmacoeconomics and Outcomes Research (ISPOR); Member of Health Economics Task Force Committee member of International Diabetes Federation. Dr. Chen graduated from Shanghai Medical University in 1966. She obtained a Master degree of Medicine in the area of Public Health in Shanghai Medical University in 1981. She also studied at Harvard University, School of Public Health in the Master program of Health Policy and Management during 1985-1986. Dr. Chen worked as a physician and paediatrician for ten years. Afterwards, she founded the Department of Hospital Management, School of Public Health, Shanghai Medical University. In 1993, she was appointed as Vice-President of Shanghai Medical University. She was also the member of the National Expert Committee of the Ministry of Health in China in the past 20 years. In 1998, Dr. Chen joined the headquarter of World Health Organization, and was appointed as Assistant Director General. As a professor in Social Medicine, Health Administration, Hospital Management, Health Technology Assessment, Health Economics and Clinical Epidemiology, she wrote more than seventy articles and books on these topics. Furthermore, she has been a tutor for more than forty students on their Masters or PhD program.

Kai Hong Phua AM cum laude SM, PhD Professor Kai Hong Phua holds a tenured appointment at the Lee Kuan Yew School of Public Policy and was previously Head, Division of Health Care and Associate Professor, Department of Community, Occupational and Family Medicine at the Faculty of Medicine, National University of Singapore. He was also an Adjunct Senior Fellow at the Institute of Policy Studies, Singapore. He graduated with honours cum laude from Harvard University and received graduate degrees from the Harvard School of Public Health (Master s in Health Services Administration & Population Sciences) and the London School of Economics & Political Science (PhD in Social Administration specializing in Health Economics). Professor Phua has produced over 100 publications and papers in the field of health care management and related areas including the history of health services, population ageing, health economics and financing. He has contributed many international publications on comparative health policy, especially organizational and financing systems, and health sector reforms in the Asia-Pacific region. At the corporate level, he was a past director of Health Management International Holdings and the NTUC Healthcare Cooperative. He has also consulted extensively for major multinational companies, including Baxter Healthcare, Johnson & Johnson, Merck Sharp & Dohme, Novartis, Pfizer, Health Industry Manufacturers Association (HIMA) and the International Federation for Pharmaceutical Manufacturers Association (IFPMA). He has undertaken healthcare consulting assignments for numerous organizations and ministries of health in Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Hong Kong, Taiwan, China, Mongolia, Korea, Japan and the Middle East. He is currently appointed to an International think tank to advise on health insurance for the Executive Council of the Dubai Government. He has consulted in health policy and management to many public, voluntary and international agencies within the Asia-Pacific region, including the Asian Development Bank, Asia-Pacific Academic Consortium for Public Health, International Red Cross/Red Crescent, United Nations Economic and Social Commission for the Asia-Pacific, World Bank and World Health Organization.

Ashoke S. Bhattacharjya PhD Ashoke Bhattacharjya is Executive Director, Health Policy and Economics, Johnson & Johnson Medical, Asia-Pacific. In this capacity, he is responsible for a broad range of economic analyses and strategic activities in support of health and innovation policy as well as reimbursement issues facing Johnson & Johnson and the healthcare industry at large. Dr. Bhattacharjya is engaged in projects related to the policy analyses of international health systems, the economics of innovation as well as evidence-based medicine. He has also held a variety of positions within Johnson & Johnson s Corporate Policy group and Janssen Pharmaceutica s research, medical affairs and business development units. Prior to joining Johnson & Johnson in 1996, he worked as an economist in Pfizer s Corporate Strategic Planning and Policy Division. Dr. Bhattacharjya was a Lecturer in the Economics Department of Columbia University as well as Instructor at NYU s Stern School of Business at various times from 1990 to 1994. He received his Ph.D in Economics from Columbia University. He has published several papers in the fields of the economics of innovation, product diffusion and competition as well as healthcare financing in leading peer-reviewed journals. He is currently a member of the scientific advisory committee of the International Health Economics Association, InHealth, Washington D.C., and ISPOR s Asia-Pacific Medical Devices Advisory Council. Dr. Bhattacharjya has received several academic honors, including the President s Fellowship at Columbia University, 1987-90 and National Merit Scholarships in India.

Kathy Cargill MSc, MRPharmS Kathy Cargill MSc, MRPharmS is Senior Director of Reimbursement and Health Economics in Medtronic International based in Tolochenaz, Switzerland. Kathy has more than 25 years of international health care-focused leadership in reimbursement, health technology assessment (HTA), health economics and pharmacy services across pharmaceutical, medical device and public health care sectors at global, regional and local levels with market leading companies GlaxoSmithKline and Medtronic and major public and private hospitals in UK and Australia. Kathy is leading an international function of expert reimbursement and health economic staff across six business areas at Europe, Emerging Markets and Canada regional and country levels to define strategies and deliver country relevant data and tools in order to gain and maintain optimal funding for Medtronic therapies. Kathy has been partnering actively on HTA, reimbursement and funding policy initiatives at global, regional and local scientific, political and industry forums. She contributed to position and publication on Coverage with Evidence Development(CED) and Harmonisation of Evidence Requirements in HTAi Policy Forum and led development of new HTA position paper in EucoMed(European medical technology industry association) and made various presentations on the value of medical devices at WHO and OECD.

Seong-Hi Park PhD Seong-Hi Park PhD is general manager of Health Technology Assessment (HTA) Team at Health Insurance Review and Assessment Service, South Korea. She is responsible for the overall management and strategic direction of HTA as well as operation of Committee for HTA. Dr. Park was appointed general manager in 2004. She is working as a member of Regional Advisory Committee HTAi 2009.